Simplex Trading’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-22,261
| Closed | -$84.4K | – | 10424 |
|
|
2026
Q1 | $85.9K | Buy |
22,261
+14,126
| +174% | +$55.6K | ﹤0.01% | 5271 |
|
|
2025
Q4 | $32K | Buy |
+8,135
| New | +$36K | ﹤0.01% | 6057 |
|
|
2025
Q3 | – | Sell |
-280
| Closed | -$1.01K | – | 10188 |
|
|
2025
Q2 | $0 | Sell |
280
-2,413
| -90% | -$7.78K | ﹤0.01% | 9848 |
|
|
2025
Q1 | $9K | Sell |
2,693
-7,381
| -73% | -$34.5K | ﹤0.01% | 7204 |
|
|
2024
Q4 | $57K | Buy |
10,074
+7,170
| +247% | +$46.2K | ﹤0.01% | 5753 |
|
|
2024
Q3 | $16K | Sell |
2,904
-1,068
| -27% | -$7.76K | ﹤0.01% | 6860 |
|
|
2024
Q2 | $31K | Sell |
3,972
-7,639
| -66% | -$64K | ﹤0.01% | 6548 |
|
|
2024
Q1 | $108K | Buy |
+11,611
| New | +$98K | ﹤0.01% | 5502 |
|
|
2023
Q4 | – | Sell |
-7,572
| Closed | -$54.9K | – | 9949 |
|
|
2023
Q3 | $58K | Buy |
+7,572
| New | +$69.1K | ﹤0.01% | 5671 |
|
|
2023
Q2 | – | Sell |
-16,623
| Closed | -$172K | – | 10059 |
|
|
2023
Q1 | $128K | Buy |
+16,623
| New | +$132K | ﹤0.01% | 4878 |
|
|
2021
Q4 | – | Sell |
-724
| Closed | -$2.47K | – | 11557 |
|
|
2021
Q3 | $2K | Buy |
+724
| New | +$2.35K | ﹤0.01% | 9575 |
|
|
2021
Q2 | – | Sell |
-2,642
| Closed | -$12K | – | 10777 |
|
|
2021
Q1 | $12K | Buy |
+2,642
| New | +$18K | ﹤0.01% | 7813 |
|
|
2020
Q4 | – | Sell |
-1,465
| Closed | -$14.1K | – | 9164 |
|
|
2020
Q3 | $15K | Buy |
1,465
+355
| +32% | +$4.17K | ﹤0.01% | 6580 |
|
|
2020
Q2 | $14K | Sell |
1,110
-985
| -47% | -$11.5K | ﹤0.01% | 6465 |
|
|
2020
Q1 | $19K | Sell |
2,095
-8,503
| -80% | -$97.6K | ﹤0.01% | 6011 |
|
|
2019
Q4 | $147K | Buy |
10,598
+4,099
| +63% | +$59.6K | ﹤0.01% | 4087 |
|
|
2019
Q3 | $111K | Sell |
6,499
-17,398
| -73% | -$365K | ﹤0.01% | 4215 |
|
|
2019
Q2 | $650K | Buy |
23,897
+7,881
| +49% | +$180K | ﹤0.01% | 2332 |
|
|
2019
Q1 | $306K | Buy |
16,016
+15,918
| +16,243% | +$207K | ﹤0.01% | 3179 |
|
|
2018
Q4 | $0 | Sell |
98
-289
| -75% | -$3.71K | ﹤0.01% | 7908 |
|
|
2018
Q3 | $7K | Buy |
387
+114
| +42% | +$2.19K | ﹤0.01% | 6624 |
|
|
2018
Q2 | $5K | Sell |
273
-100
| -27% | -$1.98K | ﹤0.01% | 6736 |
|
|
2018
Q1 | $7K | Sell |
373
-12,143
| -97% | -$262K | ﹤0.01% | 4383 |
|
|
2017
Q4 | $207K | Buy |
12,516
+12,110
| +2,983% | +$208K | 0.01% | 1246 |
|
|
2017
Q3 | $8K | Buy |
+406
| New | +$4.58K | ﹤0.01% | 4019 |
|
Other funds holding VYGR
AC
VPC
OM
Simplex Trading's VYGR Position: Q2 2026 in Review
Simplex Trading sold out of Voyager Therapeutics (VYGR) in Q2 2026, closing a stake of 22,261 shares — an estimated $84.4K sold.
Simplex Trading first reported a position in VYGR in Q3 2017 and held it in 25 quarters. The position peaked at $650K in Q2 2019. 136 funds tracked by Wall St. Rank hold VYGR as of Q2 2026.
- Simplex Trading reported no remaining Voyager Therapeutics position as of Q2 2026 after selling out during the quarter.
- Simplex Trading sold 22,261 Voyager Therapeutics shares in Q2 2026, an estimated $84.4K.
- Simplex Trading first reported a position in Voyager Therapeutics in Q3 2017 and held it in 25 quarters.
- Simplex Trading's Voyager Therapeutics position peaked at $650K in Q2 2019.
- 136 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2026.
Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.